drugset / Trial / NCT03216408
Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Moderate to Severe Glabellar Lines
RandomizedParallel-groupDouble-blindTreatment
Summary
This clinical study evaluates the efficacy and safety of Neuronox compared with Botox in adults with moderate to severe glabellar lines.
Timeline
- Start
- 2016-03-30
- Primary completion
- 2016-11-10
- Completion
- 2017-03-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | — | — |
| Subject | Neuronox | Protein / enzyme biologic | — | — |
Indications
No indication recorded.